Segall Bryant & Hamill LLC Trims Position in Orthofix International NV (OFIX)

Segall Bryant & Hamill LLC lessened its stake in Orthofix International NV (NASDAQ:OFIX) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 664,644 shares of the medical device company’s stock after selling 16,238 shares during the period. Orthofix International comprises 0.9% of Segall Bryant & Hamill LLC’s portfolio, making the stock its 27th biggest holding. Segall Bryant & Hamill LLC owned approximately 3.54% of Orthofix International worth $39,068,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ramsey Quantitative Systems bought a new stake in shares of Orthofix International in the fourth quarter valued at about $247,000. AXA raised its position in Orthofix International by 44.9% in the fourth quarter. AXA now owns 91,650 shares of the medical device company’s stock worth $5,013,000 after purchasing an additional 28,400 shares in the last quarter. Bogle Investment Management L P DE raised its position in Orthofix International by 42.6% in the fourth quarter. Bogle Investment Management L P DE now owns 62,971 shares of the medical device company’s stock worth $3,444,000 after purchasing an additional 18,804 shares in the last quarter. Teachers Advisors LLC raised its position in Orthofix International by 1.9% in the fourth quarter. Teachers Advisors LLC now owns 327,421 shares of the medical device company’s stock worth $17,910,000 after purchasing an additional 6,117 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. raised its position in Orthofix International by 6.6% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 124,067 shares of the medical device company’s stock worth $6,787,000 after purchasing an additional 7,673 shares in the last quarter. Institutional investors and hedge funds own 91.78% of the company’s stock.

Shares of Orthofix International traded down $0.26, hitting $57.86, during mid-day trading on Thursday, according to Marketbeat.com. 820 shares of the stock were exchanged, compared to its average volume of 140,477. The firm has a market cap of $1.06 billion, a price-to-earnings ratio of 35.88, a PEG ratio of 3.50 and a beta of 0.26. Orthofix International NV has a twelve month low of $42.68 and a twelve month high of $61.86.



Orthofix International (NASDAQ:OFIX) last posted its quarterly earnings data on Monday, April 30th. The medical device company reported $0.39 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.03. The company had revenue of $108.71 million during the quarter, compared to analyst estimates of $107.10 million. Orthofix International had a net margin of 3.21% and a return on equity of 11.08%. The company’s revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the business posted $0.27 earnings per share. research analysts expect that Orthofix International NV will post 1.66 earnings per share for the current year.

Several research analysts recently issued reports on the stock. BidaskClub lowered shares of Orthofix International from a “hold” rating to a “sell” rating in a research report on Thursday, February 15th. Cantor Fitzgerald assumed coverage on shares of Orthofix International in a research report on Thursday, May 31st. They issued an “overweight” rating and a $62.00 price target for the company. ValuEngine raised shares of Orthofix International from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Gabelli reissued a “buy” rating on shares of Orthofix International in a research report on Wednesday, February 28th. Finally, Zacks Investment Research lowered shares of Orthofix International from a “hold” rating to a “sell” rating in a research report on Saturday, May 5th. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $58.07.

In other news, Director Ronald A. Matricaria acquired 10,000 shares of the company’s stock in a transaction dated Thursday, May 3rd. The stock was bought at an average price of $51.97 per share, with a total value of $519,700.00. Following the completion of the acquisition, the director now owns 101,613 shares in the company, valued at approximately $5,280,827.61. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 5.60% of the company’s stock.

About Orthofix International

Orthofix International N.V., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures.

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International NV (NASDAQ:OFIX).

Institutional Ownership by Quarter for Orthofix International (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply